Inflammatory Bowel Diseases - 16th Congress of ECCO Virtual July 2-3 & 8-10, 2021
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Virtual
Inflammatory
Bowel Diseases
Pocket Guide
ircle Bridge” by Maria Eklind
16th Congress of ECCO
Virtual
July 2-3 & 8-10, 2021
www.ecco-ibd.eu
ECCO’21 Virtual Congress | About ECCO
Key Dates
June 28, 2021 ECCO‘21 Virtual Congress Platform opens
July 2-3, 2021
July 8-10, 2021
Educational Programme
16th Congress of ECCO 2021: Scientific
Programme
ECCO IBD APP
ECCO Congress Office
July 2, 2021 07:00 - 19:00 CEST Down
loa
July 3, 2021 07:00 - 17:00 CEST now! d
July 5-7, 2021 09:00 - 17:00 CEST
July 8, 2021 07:00 - 19:00 CEST
July 9, 2021 07:00 - 19:00 CEST
July 10, 2021 07:00 - 16:00 CEST
About ECCO
ECCO strives for optimisation of care for patients with IBD in all aspects.
As part of this mission ECCO adopts and further all efforts that lead to
an improvement of the use of current therapies and procedures. Main
aims include the development of guidelines with highest possible
methodology and content quality and joint efforts to define better
and more valid outcome parameters for the therapy of IBD.
Further aspects of the mission include the promotion of specialist,
postgraduate education in IBD, as well as scientific projects in IBD.
Such promotion can include intellectual input, funding and joint The World of ECCO
training using an ECCO defined curriculum. ECCO’s visibility will
always be as an organisation and not as the individuals making up
in your pocket
ECCO. With all its activities the name of ECCO will stand in the world Features and Benefits:
of gastroenterology for the highest possible level in quality and full • Listen to Audio Podcasts and
impartiality in the results. watch Talking Heads on the go
• Discover the e-Guide
ECCO Office • Access ECCO News at any time
• Find more ECCO Initiatives at one glance
Ungargasse 6/13 • Stay up-to-date in the IBD World
1030 Vienna, Austria
Phone: +43-(0)1-710 22 42 • Explore the ECCO’21 Congress
Fax: +43-(0)1-710 22 42-001
E-Mail: ecco@ecco-ibd.eu Available in App Stores free of charge:
Web: www.ecco-ibd.eu
2 16th Congress of ECCO - European Crohn‘s and Colitis Organisation
Scientific programme day by day “IBD precise”
“IBD precise” 10: Are we safer with biologics or
14:25 - 14:40 small-molecules?
E. Louis, Liège, Belgium
11: OP05: Association of ultra-processed food intake
with risk of Inflammatory Bowel Disease from the
Thursday, July 8, 2021 14:40 - 14:50 prospective urban rural epidemiology (PURE) study:
Scientific programme day by day A prospective cohort study
N. Narula, Hamilton, Canada
12: OP06: 5-aminosalicylates are not associated
11:00 - 12:00 Industry Sponsored Satellite Symposia
1a, 1b &1c with adverse outcomes in Inflammatory Bowel
14:50 - 15:00 Disease patients with COVID-19: Analysis from an
12:15 - 12:30 1: Opening
L. Peyrin-Biroulet, Vandœuvre-Lès-Nancy, France international registry
R. Ungaro, New York, United States
Scientific Session 1: Sophisticated strategies within
13: Are surgical interventions really more harmful
12:30 - 13:45 reach 15:00 - 15:15 than medical treatment?
P. Irving, London, United Kingdom
S. Vermeire, Leuven, Belgium O. Faiz, Harrow, United Kingdom
15:15- 15:30 Break
12:30 - 12:45 2: Head to head trials
S. Ghosh, Cork, Ireland Scientific Session 3: Hot and (almost) happening
3: OP01: Comparison of fecal transplantation, 15:30 - 16:35 J. Burisch, Hvidovre, Denmark
fecal transplantation with the novel UC diet or C. Maaser, Lüneburg, Germany
15:30 - 15:45 14: How machine learning will affect IBD treatment
12:45 - 12:55 the UC diet alone for Refractory Mild to Moderate
Active Ulcerative Colitis: The CRAFT UC randomized S. Ennis, Southampton, United Kingdom
controlled trial 15: Artificial intelligence: A strategic alliance
A. Levine, Holon, Israel 15:45 - 16:00 between the machine and the endoscopist
4: Switching from IV to SC: Benefits beyond merely P. Bossuyt, Bonheiden, Belgium
12:55 - 13:10 convenience? 16: OP07: Artificial intelligence surpasses
S. Schreiber, Kiel, Germany
16:00 - 16:10 gastrointestinal experts in the classification of
5: OP02: Ustekinumab versus adalimumab for endoscopic severity among Ulcerative Colitis
B. Lo, Hvidovre, Denmark
13:10 - 13:20 induction and maintenance therapy in Moderate-to-
Severe Crohn’s Disease: The SEAVUE study 17: OP08: Automatic detection of enteric ulcers and
P. Irving, London, United Kingdom
16:10 - 16:20 erosions in capsule endoscopy using a convolutional
6: OP03: Anti-SARS-CoV2 antibody responses are neural network
M. Saraiva, Porto, Portugal
13:20 - 13:30 attenuated in patients with Inflammatory Bowel
Disease treated with infliximab
16:20 - 16:35 18: How to set-up a virtual clinic?
N. Kennedy, Exeter, United Kingdom M. Pierik, Maastricht, The Netherlands
13:30 - 13:45 7: Combining biologics: Pros and cons 16:35- 16:45 Break
D. Rubin, Chicago, United States
16:45 - 17:45 Digital Oral Presentations (Sessions 1-5)
13:45 - 14:00 Break
17:45- 17:55 Break
Scientific Session 2: Safety first?
17:55 - 18:55 Industry
14:00 - 15:15 M. Adamina, Winterthur, Switzerland Sponsored Satellite Symposia
L. Lopetuso, Rome, Italy 2a , 2b & 2c
8: When do we really know the safety profile of a
14:00 - 14:15 drug?
J. Rahier, Yvoir, Belgium
9: OP04: Safety analysis of filgotinib for Ulcerative
Colitis: Results from the phase 2b/3 SELECTION study
14:15 - 14:25 and phase 3 SELECTIONLTE long-term extension
study
S. Schreiber, Kiel, Germany
4 16th Congress of ECCO - European Crohn‘s and Colitis Organisation July 2-3 & 8-10, 2021 • Virtual 5
Scientific programme day by day “IBD precise”
Friday, July 9, 2021 10:15 - 10:30 27: The future of radiology for IBD
A. Laghi, Rome, Italy
Scientific programme day by day
10:30 - 10:45 Break
Scientific Session 5: The young and the old
07:15 - 08:15 Industry Sponsored Morning Satellite Symposia
3a, 3b & 3c 10:45 - 12:00 T. Raine, Cambridge, United Kingdom
P. Van Rheenen, Groningen, The Netherlands
Scientific Session 4.1.: Next generation diagnostics
08:30 - 09:20 T. Kucharzik, Lüneburg, Germany 28: Lessons from paediatric IBD – early disease
N. Yassin, Birmingham, United Kingdom 10:45 - 11:00 intervention, nutrition, genetic testing
J. Van Limbergen, Amsterdam, The Netherlands
19: What histology can tell us: Are we speaking the
29: OP15: Cyclic exclusive enteral nutrition to
08:30 - 08:50 same language?
R. Feakins, London, United Kingdom maintain longterm drug-free remission in Paediatric
F. Magro Dias, Porto, Portugal 11:00 - 11:10 Crohn’s Disease: the CD HOPE study of the GETAID
pédiatrique
20: OP09: Patient reported outcomes reflect B. Pigneur Arnaud, Paris, France
08:50 - 09:00 histologic disease activity in patients with Ulcerative
11:10 - 11:25 30:
Colitis: Interim analysis of the APOLLO study Drug safety in the elderly patients with IBD
B. Verstockt, Leuven, Belgium T. Lobatón Ortega, Ghent, Belgium
21: OP10: Response to biologics in IBD patients 31: OP16: Characterization of the Clinical Features
assessed by Computerized image analysis of and Outcomes of Paediatric Patients with Isolated
09:00 - 09:10 Probe Based Confocal Laser Endomicroscopy with 11:25 - 11:35 Colonic Crohn’s Disease: A Multi-center Study from
molecular labeling and gene expression profiling the Porto Group of ESPGHAN
M. Iacucci, Birmingham, United Kingdom D. Shouval, Petah Tiqwa, Israel
22: OP11: Longitudinal profiling of mucosal 32: OP17: Impact of phenotypic and genetic factors
11:35 - 11:45 on
immune cell composition using multiplex Crohn’s Disease evolution in a cohort of 13,926
09:10 - 09:20 immunohistochemistry identifies drug- and patients
response-specific patterns in Ulcerative Colitis Q. Zhang, Cambridge, United Kingdom
V. Volk, Hannover, Germany
11:45 - 12:00 33: Body image and sexuality
09:20 - 09:30 Break P. Tozer, London, United Kingdom
Scientific Session 4.2.: Next generation diagnostics 12:00 - 12:10 Break
09:30 - 10:30 T. Kucharzik, Lüneburg, Germany
12:10 - 12:50 Industry Sponsored Lunch Satellite Symposia LS1,
N. Yassin, Birmingham, United Kingdom LS2, LS3 & LS4
09:30 - 09:45 23: Fluorescence in IBD surgery 12:50 - 13:00 Break
M. Slooter, Amsterdam, The Netherlands Scientific Session 6: Bottoms behaving badly
24: OP12: Blood proteins related to 13:00 - 14:15 A. Armuzzi, Rome, Italy
immunoregulation or cellular junctions reveal Z. Zelinkova, Bratislava, Slovakia
09:45 - 09:55 distinct biological profiles associated with the risk of
13:00 - 13:15 34: New surgical approaches for perianal disease
short-term versus mid/long-term relapse in Crohn’s P. Kotze, Curitiba, Brazil
Disease patients stopping infliximab
N. Pierre, Liège, Belgium 35: OP18: Treatment of perianal fistulas in Crohn’s
Disease: Surgical closure after anti-TNF induction
25: OP13: Mucosal organoids capture Innate 13:15 - 13:25 treatment versus anti-TNF without surgery (PISA II) -
Lymphoid Cells (ILC) tissue-specific development and A patient preference RCT
09:55 - 10:05 reveal that Inflammatory Bowel Disease-associated E. Meima-van Praag, Amsterdam, The Netherlands
ILC modulate intestinal remodelling
13:25 - 13:40 36:
J. Neves, London, United Kingdom Looking beyond anti-TNF
S. Vavricka, Zurich, Switzerland
26: OP14: Extracellular RNAs as liquid biopsy non- 37: OP19: Disease course and treatment outcomes
10:05 - 10:15 invasive biomarker in IBD
B. Verstockt, Leuven, Belgium 13:40 - 13:50 of early resected Crohn‘s Disease patients: A Danish
nationwide cohort study from 1997 to 2015
M. Zhao, Hvidovre, Denmark
6 16th Congress of ECCO - European Crohn‘s and Colitis Organisation July 2-3 & 8-10, 2021 • Virtual 7
Scientific programme day by day “IBD precise”
Friday, July 9, 2021, cont. 47: OP26: Risankizumab induces early clinical
remission and response in patients with Moderate-
Scientific programme day by day 16:05 - 16:15 to-Severe Crohn’s Disease: Results from the phase 3
ADVANCE and MOTIVATE studies
38: OP20: Risk and predictors of surgery in a newly S. Schreiber, Kiel, Germany
13:50 - 14:00 diagnosed cohort of IBD patients in the biologic era: 48: OP27- WITHDRAWN
Results from the EpidemIBD study
M. Chaparro, Madrid, Spain 49: OP28: The effect of guselkumab induction
therapy on early clinical outcome measures in
14:00 - 14:15 39: When it is not IBD
G. Bouguen, Rennes, France 16:15 - 16:25 patients with Moderately to Severely Active Crohn’s
Disease: Results from the phase 2 GALAXI 1 study
14:15 - 14:30 Break S. Danese, Rozzano, Italy
Scientific Session 7: Milestones in clinical care 16:25- 16:45 Break
14:30 - 15:20 R. Atreya, Erlangen, Germany
P. Gionchetti, Bologna, Italy 16:45 - 17:45 Digital Oral Presentations (Sessions 6-10)
40: Endoscopy or ultrasound for disease activity 17:45- 17:55 Break
14:30 - 14:45 assessment? 17:55 - 18:55 Industry Sponsored Satellite Symposia 4a, 4b & 4c
M. Iacucci, Birmingham, United Kingdom
M. Allocca, Rozzano, Italy
41: OP21: Predictive value of Milan Ultrasound Crite-
14:45 - 14:55 ria in Ulcerative Colitis: A prospective observational
cohort study
M. Allocca, Rozzano, Italy
42: OP22: Factors independently associated with
14:55 - 15:05 fatigue in IBD: Results from the baseline dataset of
the PREdiCCt study
L. Derikx, Edinburgh, United Kingdom
43: ECCO Guidelines: Prevention and management
15:05 - 15:20 of Opportunistic Infections
T. Kucharzik, Lüneburg, Germany
S. Vavricka, Zurich, Switzerland
15:20 - 15:35 Break
Scientific Session 8: IBD Horizons
15:35 - 16:25 B. Verstockt, Leuven, Belgium
J. Torres, Loures, Portugal
44: OP23: Efficacy and safety of upadacitinib as
induction therapy in patients with Moderately to
15:35 - 15:45 Severely Active Ulcerative Colitis: Results from phase
3 U-ACCOMPLISH study
S. Vermeire, Leuven, Belgium
45: OP24: Efficacy and safety of upadacitinib
induction therapy in patients with Moderately to
15:45 - 15:55 Severely Active Ulcerative Colitis: Results from the
phase 3 U-ACHIEVE study
S. Danese, Rozzano, Italy
46: OP25: Efficacy of filgotinib in patients with
15:55 - 16:05 Ulcerative Colitis by line of therapy in the phase
2b/3 SELECTION trial
I. Dotan, Petah Tikva, Israel
8 16th Congress of ECCO - European Crohn‘s and Colitis Organisation July 2-3 & 8-10, 2021 • Virtual 9
Scientific programme day by day “IBD precise”
Saturday, July 10, 2021 10:35 - 10:50 59: Deep healing
M. Ferrante, Leuven, Belgium
Scientific programme day by day
60: OP34: AJM300, an Oral Antagonist of α4-
07:15 - 08:15 Industry Sponsored Satellite Symposia 5a & 5b Integrin, as induction therapy for patients with
10:50 - 11:00 moderately active Ulcerative Colitis: A Phase 3,
Scientific Session 9: Basic Science: The microbiome randomized, double-blind, placebo-controlled
08:30 - 09:55 as game changer in IBD? induction study
A. Kaser, Cambridge, United Kingdom M. Watanabe, Tokyo, Japan
P. Rosenstiel, Kiel, Germany
11:00 - 11:10 Break
50: Current knowledge: What is the problem with
08:30 - 08:45 FMT therapy? Scientific Session 10.2.: CD and UC: Similar disease
M. Joossens, Ghent, Belgium burden and treatment goals?
11:10 - 12:00 Is it the organ or the disease process?
51: OP29: Long-term dietary patterns are associated I. Dotan, Petah Tikva, Israel
08:45 - 08:55 with pro-inflammatory and anti-inflammatory A. Spinelli, Rozzano, Italy
features of the gut microbiome
L. Bolte, Groningen, The Netherlands 61: Can we cure IBD with surgery?
11:10 - 11:30 J. Colombel, New York, United States
52: OP30: Lyophilised orally administered faecal T. Pinkney, Birmingham, United Kingdom
08:55 - 09:05 microbiota transplantation for Active Ulcerative
Colitis (LOTUS study) 62: OP35: Effect of maintenance ustekinumab
C. Haifer, Sydney, Australia on corticosteroid-free endoscopic and clinical
11:30 - 11:40 outcomes in patients with Crohn‘s Disease - Week
09:05 - 09:20 53: Precision editing of the gut microbiota 48 analysis of the STARDUST trial
S. Zeissig, Dresden, Germany S. Danese, Rozzano, Italy
54: OP31: RESTORE: Interim analysis of a Phase 63: OP36: Risankizumab therapy induces
2 study of QBECO SSI for the induction and improvements in endoscopic endpoints in patients
09:20 - 09:30 maintenance of clinical and endoscopic remission in 11:40 - 11:50 with Moderate-to-Severe Crohn’s Disease: Results
subjects with Moderate to Severe Crohn’s Disease from the phase 3 ADVANCE and MOTIVATE studies
B. Bressler, Vancouver, Canada P. Bossuyt, Bonheiden, Belgium
55: OP32: Stool microbiome communities predict 64: OP37: Rapidity of symptom improvements
remission in treatment-naïve Pediatric Crohn’s during filgotinib induction therapy in patients with
09:30 - 09:40 Disease patients
11:50 - 12:00 Ulcerative Colitis: Post hoc analysis of the phase
C. Verburgt, Amsterdam, The Netherlands 2b/3 SELECTION study
56: Remote control of immune and metabolic S. Danese, Rozzano, Italy
09:40 - 09:55 homeostasis by the gut microbiome and its 12:00 - 13:00 Break
potential impact on health
M. Chamaillard, Lille, France 12:10 - 12:50 Industry Sponsored Satellite Symposia LS5 & LS6
09:55 - 10:10 Break Scientific Session 11: Personalised medicine
13:00 - 14:15 U. Kopylov, Tel Aviv, Israel
Scientific Session 10.1.: CD and UC: Similar disease J. Gisbert, Madrid, Spain
burden and treatment goals?
13:00 - 13:15 65:
10:10 - 11:00 Is it the organ or the disease process? Stratified management for mild and severe IBD?
I. Dotan, Petah Tikva, Israel J. Halfvarson, Örebro, Sweden
A. Spinelli, Rozzano, Italy 66: OP38: Developing a Cost-Effective Genomic
Biomarker of Cancer Risk in Patients with Ulcerative
10:10 - 10:25 57: Disease burden
13:15 - 13:25 Colitis
C. Le Berre, Nantes, France using Low-Pass Whole Genome Sequencing
of Unselected Endoscopic Biopsies: A Case-Control
58: OP33: Oral ritlecitinib and brepocitinib in Study
10:25 - 10:35 patients with Moderate to Severe Active Ulcerative I. Al Bakir, London, United Kingdom
Colitis: Data from the VIBRATO umbrella study
W. Sandborn, La Jolla, United States
10 16th Congress of ECCO - European Crohn‘s and Colitis Organisation July 2-3 & 8-10, 2021 • Virtual 11
Scientific programme day by day
Saturday, July 10, 2021, cont.
Scientific programme day by day
67: Precision medicine to prevent disease
13:25 - 13:40 complications
M. Scharl, Zurich, Switzerland
ECCO’21
68: OP39: The effect of phenotype and genotype on
13:40 - 13:50 the plasma proteome in patients with Inflammatory
Bowel Disease Webcasts New:
sessio All
onlinens
A. Bourgonje, Groningen, The Netherlands
69: OP40: Analysis of clinical features associated
with favourable outcomes from ustekinumab treat- !
13:50 - 14:00 to-target strategy in Crohn’s Disease patients in the
STARDUST trial
S. Danese, Rozzano, Italy
14:00 - 14:15 70: Personalised surgery in IBD
C. Buskens, Amsterdam, The Netherlands
14:15 - 14:25 Break
Scientific Session 12: ECCO Lecture
14:25 - 15:15 L. Peyrin-Biroulet, Vandœuvre-Lès-Nancy, France
B. Siegmund, Berlin, Germany
71: SARS-CoV-2 vaccination completed – end of
14:25 - 14:40 pandemic?
T. Ahmad, Exeter, United Kingdom
72: ECCO Lecture: IBD clinical trials: Where do we
14:40 - 15:00 go from here?
W. Sandborn, La Jolla, United States
15:00 - 15:15 The ECCO Film
Missed an excellent
presentation at the Congress?
• All ECCO Members: Watch video recordings of
ECCO’21 and past Congresses on the e-CCO Learning
Platform
• All registered ECCO’21 congress participants:
Watch on-demand recordings on the virtual platform
until the end of October
• Availability is subject to speaker authorisation
• Scientific programme webcasts
• Digital oral presentation webcasts
• Educational programme webcasts
Scan and visit
12 16th Congress of ECCO - European Crohn‘s and Colitis Organisation
www.e-learning.ecco-ibd.eu
Digital oral presentations Digital oral presentations
Digital oral
presentations (DOP)
Thursday, July 8, 2021 Friday, July 9, 2021
16:45 - 17:45 Digital Oral Presentations Sessions 1-5 16:45 - 17:45 Digital Oral Presentations Sessions 6-10
Digital Oral Presentation Real-world evidence and pregnancy
Digital Oral Presentation Molecular profiling
A. Hart, London, United Kingdom M. Iacucci, Birmingham, United Kingdom
Session 1 Session 6
Y. Chowers, Haifa, Israel A. Walsh, Manchester, United Kingdom
Simple tools to predict drug response
Digital Oral Presentation Revisiting imaging and endoscopy
S. Vavricka, Zurich, Switzerland Digital Oral Presentation and disease course
Session 2 Session 7 P. Juillerat, Bern, Switzerland
G. Mantzaris , Athens, Greece
S. Ghosh, Cork, Ireland
Digital Oral Presentation New biomarkers
S. Ben-Horin, Tel Aviv, Israel Evolving therapeutic strategies
Session 3 Digital Oral Presentation E. Louis, Liege, Belgium
R. Atreya, Erlangen, Germany
Optimizing surgery outcomes Session 8 M. Löwenberg, Amsterdam, The
Digital Oral Presentation M. Adamina, Winterthur, Switzerland Netherlands
Session 4 W. Bemelman, Amsterdam, The Pharmacokinetics, COVID and new
Netherlands Digital Oral Presentation classifications
Session 9 X. Roblin, Saint Etienne, France
Digital Oral Presentation Recent advances in epidemiology
M. Aloi, Rome, Italy F. Magro Dias, Porto, Portugal
Session 5
Digital Oral Presentation New
V. Pittet, Lausanne, Switzerland data from landmark studies
I. Dotan, Petah Tikva, Israel
Session 10 A. Dignass, Frankfurt, Germany
14 16th Congress of ECCO - European Crohn‘s and Colitis Organisation July 2-3 & 8-10, 2021 • Virtual 15
e-Poster exhibition
e-Poster Exhibition
The e-Poster Exhibition is available online on the Virtual
Congress Platform from June 28, 2021 until October 31, 2021. Why submit your
You can access the e-Poster Exhibition by clicking on ‘e-Posters’ on
the Landing Page on the Virtual Congress Platform.
research to JCC?
You can filter all e-Posters by Abstract category and search for specific
keywords. Feel free to get in touch with the authors via the contact
form provided.
Prompt and professional
peer review
JCC publishes research that has undergone rigorous
peer review, including an initial screening by one of
the Editors and recommendations by independent
reviewers. The average time from submission to first
decision is two weeks.
High Impact Factor
With its 2019 Impact Factor, which now stands at
8.658, JCC ranks highly among gastroenterology and
hepatology journals.
Scan and visit
16 16th Congress of ECCO - European Crohn‘s and Colitis Organisation
www.ecco-ibd.eu
July 2-3 & 8-10, 2021 • Virtual 17
3rd ECCO Basic Imaging Workshop 3rd ECCO Basic Imaging Workshop
in collaboration with ESGAR in collaboration with ESGAR
Educational programme Ultrasound and MRI – Hands-on bowel
08:05 - 10:35 ultrasonography and interactive discussion on
Ultrasound MRI workstations
ECCO aims to promote education and improve the quality of Management of suspected IBD
T. Kucharzik, Lüneburg, Germany
care for IBD patients throughout Europe. Thus, ECCO offers J. Rimola, Barcelona, Spain
the following educational activities on July 2 & 3, prior to the S. Vavricka, Zurich, Switzerland
16th Congress of ECCO, which is held virtually. N. Capozzi, Bologna, Italy
Assessment of Crohn's Disease activity
3rd ECCO Basic Imaging R. Wilkens, Copenhagen, Denmark
J. Bjerrum, Copenhagen, Denmark
Workshop in collaboration with C. Puylaert, Amsterdam, The Netherlands
D. Bellini, Latina, Italy
ESGAR Intestinal complications of Crohn's Disease
C. Palmela, Loures, Portugal
A. Gupta, London, United Kingdom
Date: Friday, July 2, 2021 F. Petersen, Lüneburg, Germany
Time: 07:30-15:20 J. Tielbeek, Amsterdam, The Netherlands
Organisation: EduCom in collaboration with ESGAR 08:05 - 10:35
Recommended for: Physicians, Radiologists, Surgeons, Paediatricians Post-operative recurrence of Crohn's Disease
Other professions are kindly invited to register. M. Allocca, Rozzano, Italy
Registration: ECCO Membership 2021 required L. White, Sunshine Coast, Australia
K. Horsthuis, Amsterdam, The Netherlands
Online registration C. Bonifacio, Milan, Italy
Registration fee: 120 EUR (incl. 20% Austrian VAT)
50% reduction for Y-ECCO, Affiliate & IBD Nurse Perianal Crohn's Disease
Members D. Carter, Ramat Gan, Israel
CME accreditation: 6 CME credits; prerequisite: completion of the F. Maccioni, Rome, Italy
online evaulation form C. Maaser, Lüneburg, Germany
M. Amitai, Tel Aviv, Israel
Ulcerative Colitis
Friday, July 2, 2021 K. Gecse, Amsterdam, The Netherlands
A. Radmard, Tehran, Iran
ECCO-ESGAR Basic Imaging Workshop IUS/MRI Part S. Cakovic-Cavka, Zagreb, Croatia
P. Paolantonio, Rome, Italy
1: Welcome & Introduction
07:30 - 07:35 P. Paolantonio, Rome, Italy 10:35 - 11:05 Ultrasound and MRI – Lectures Part 2
C. Maaser, Lüneburg, Germany 4: When IUS, when MRI in daily IBD practice?
07:35 - 08:05 Ultrasound and MRI – Introductory lectures 10:35 - 11:05 T. Kucharzik, Lüneburg, Germany
J. Rimola, Barcelona, Spain
07:35 - 07:50 2: Entero-MRI – What to look for
P. Paolantonio, Rome, Italy 5: Farewell
11:05 - 11:10 P. Paolantonio, Rome, Italy
07:50 - 08:05 3: Intestinal ultrasound – What to look for
C. Palmela, Loures, Portugal
C. Maaser, Lüneburg, Germany
11:10 - 11:40 Break
ECCO-ESGAR Basic Imaging Workshop Endoscopy Part
6: Welcome & Introduction
11:40 - 11:45 F. Magro Dias, Porto, Portugal
M. Iacucci, Birmingham, United Kingdom
Session 1: Endoscopy – Driving quality in IBD
11:45 - 13:05 endoscopy
B. Hayee, London, United Kingdom
18 16th Congress of ECCO - European Crohn‘s and Colitis Organisation July 2-3 & 8-10, 2021 • Virtual 193rd ECCO Basic Imaging Workshop 19th IBD Intensive Course for Trainees
in collaboration with ESGAR
7: Key quality indicators for endoscopy in IBD: Why
11:45 - 12:00 do we need them?
19th IBD Intensive Course for
M. Iacucci, Birmingham, United Kingdom
8: Interactive endoscopy video cases: How to score
Trainees
12:00 - 12:15 and
CD?
how to write “good quality reports“ in UC and
Date: Friday, July 2, 2021
R. Cannatelli, Brescia, Italy Time: 08:00-13:45
9: Interactive endoscopy video cases: How to Organisation: EduCom
Recommended for: Junior gastroenterologists
12:15 - 12:30 score and how to write a “good quality report “on
surveillance colonoscopy? Registration: ECCO Membership 2021 required. Upon
M. Iacucci, Birmingham, United Kingdom invitation only
10: Interactive endoscopy video cases: How to CME accreditation: 5 CME credits; prerequisite: completion of the
12:30 - 13:05 score and write a “good quality report “during
enteroscopy and pouchscopy?
online evaulation form
P. Ellul, Msida, Malta Friday, July 2, 2021
13:05 - 13:20 Break 1: Welcome & Introduction from the course director
Session 2: Endoscopy – Surveillance and 08:00 - 08:05 H. Yanai, Petah Tikva, Israel
F. Magro Dias, Porto, Portugal
13:20 - 14:20 management of dysplasia in IBD: Do we still need to
use a dye in 2021? L. Peyrin-Biroulet, Vandœuvre-Lès-Nancy, France
M. Iacucci, Birmingham, United Kingdom Session 1: Introduction and case-based
11: Dyeless or still dye chromoendoscopy: How do 08:05 - 09:30 management on conventional IBD therapies
Lead discussant: J. Lindsay, London, United Kingdom
13:20 - 13:35 Iexcellent
use curriculum to achieve competency and be an
IBD endoscopist? 2: IBD: Epidemiology, immunopathogenesis, and
R. Bisschops, Leuven, Belgium 08:05 - 08:30 their relevance to therapeutics
12: Advanced dysplasia characterization and I. Dotan, Petah Tikva, Israel
13:35 - 13:50 therapeutic management: New tools and techniques
B. Hayee, London, United Kingdom 08:30 - 08:45 3: 5-ASA compounds
S. Hanauer, Chicago, United States
13: Interactive endoscopy video cases in dysplasia:
13:50 - 14:20 What to look for and how to do it? 08:45 - 09:00 4: Thiopurines
P. Irving, London, United Kingdom
B. Hayee, London, United Kingdom 5: Methotrexate
Session 3: Endoscopy - What is the future at the 09:00 - 09:15 P. Juillerat, Bern, Switzerland
14:20 - 15:20 horizon in IBD endoscopy?
P. Ellul, Msida, Malta 09:15 - 09:30 6: Steroids
H. Yanai, Petah Tikva, Israel
14: Artificial Intelligence in IBD: Do I see better than 09:30 - 09:45 Break
14:20 - 14:40 we do?
R. Bisschops, Leuven, Belgium Session 2: Case-based management of conventional
15: Interactive endoscopic video cases: How to score 09:45 - 11:25 IBD therapies
14:40 - 15:15 IBD activity through the endoscope and the AI eyes Lead discussant: A. Dignass, Frankfurt, Germany
M. Iacucci, Birmingham, United Kingdom 09:45 - 10:05 7: Anti-TNF agents and TDM
P. Michetti, Lausanne, Switzerland
15:15 - 15:20 16: Closing remarks
M. Iacucci, Birmingham, United Kingdom 8: Anti-integrins
10:05 - 10:20 J. Lindsay, London, United Kingdom
10:20 - 10:35 9: Anti-IL 23
M. Ferrante, Leuven, Belgium
10:35 - 10:50 10: JAK inhibitors
S. Vermeire, Leuven, Belgium
11: Medication in the pipeline
10:50 - 11:05 L. Peyrin-Biroulet, Vandœuvre-Lès-Nancy, France
11:05 - 11:25 12: Positioning therapeutic strategies in IBD
S. Ben-Horin, Ramat Gan, Israel
11:25 - 11:55 Break
20 16th Congress of ECCO - European Crohn‘s and Colitis Organisation July 2-3 & 8-10, 2021 • Virtual 2119th IBD Intensive Course for Trainees 4th School for Clinical Trialists
11:55 - 13:40 Session 3: Round tables – 7 Themes / clinical cases
discussion
13a: Pregnancy
4th School for Clinical Trialists
J. van der Woude, Rotterdam, The Netherlands Date: Friday, July 2, 2021
I. Dotan, Petah Tikva, Israel
13b: Extraintestinal manifestations Time: 08:00-10:55
K. Karmiris, Heraklion, Greece Organisation: ClinCom
P. Lakatos, Budapest, Hungary Recommended for: Clinical trial coordinators, IBD Nurses and Allied
13c: When and how to start biologics? health professionals
A. Dignass, Frankfurt, Germany Other professions are kindly invited to register.
G. Mantzaris, Athens, Greece Registration: ECCO Membership 2021 required
13d: Complications associated with anti-TNF Online registration
11:55 - 13:40 therapy
S. Ben-Horin, Ramat Gan, Israel Registration fee: 40 EUR (incl. 20% Austrian VAT)
Y. Chowers, Haifa, Israel CME accreditation: 2 CME credits; prerequisite: completion of the
13e: Therapeutic Drug Monitoring online evaulation form
P. Juillerat, Bern, Switzerland
S. Vavricka, Zurich, Switzerland
13f: Exit strategy Friday, July 2, 2021
M. Ferrante, Leuven, Belgium
08:00 - 08:05 1: Welcome & Introduction
G. Fiorino, Rozzano, Italy L. Beaugerie, Paris, France
13g: Therapeutic Endoscopy in IBD
P. Michetti, Lausanne, Switzerland Session 1: Drug efficacy
08:05 - 09:25 P. Bossuyt,
H. Yanai, Petah Tikva, Israel Bonheiden, Belgium
13:40 - 13:45 14: Summary and conclusions 2: Drug efficacy: What are the expectations?
H. Yanai, Petah Tikva, Israel
08:05 - 08:25 A. Walsh, Oxford, United Kingdom
G. Wakefield, Bicester, United Kingdom (Patient
Representative)
3: Do we still need RCTs?
08:25 - 08:45 G. D‘Haens, Amsterdam, The Netherlands
U. Kopylov, Tel Aviv, Israel
4: Personalized prediction: Statistician or algorithm?
08:45 - 09:05 S. Bonovas, Milan, Italy
P. Dulai, San Diego, United States
5: Discussion
A. Walsh, Oxford, United Kingdom
G. Wakefield, Bicester, United Kingdom (Patient
Representative)
09:05- 09:25 G. D’Haens, Amsterdam, The Netherlands
U. Kopylov, Tel Aviv, Israel
S. Bonovas, Milan, Italy
P. Dulai, San Diego, United States
P. Bossuyt, Bonheiden, Belgium
09:25 - 09:40 Break
09:40 - 10:50 Session 2: Drug safety
L. Beaugerie, Paris, France
09:40 - 09:55 6: Classical pharmacovigilance: Still useful? (ANSM)
A. Inoubli, Saint-Denis, France
22 16th Congress of ECCO - European Crohn‘s and Colitis Organisation July 2-3 & 8-10, 2021 • Virtual 234th School for Clinical Trialists 12th N-ECCO School
7: How investigator-initiated studies have 12th N-ECCO School
09:55 - 10:10 substantially changed the safety profile of IBD drugs
J. Kirchgesner, Paris, France Date: Friday, July 2, 2021
8: Communicating risks – IBD research nurse and Time: 09:30-14:15
physician perspective Organisation: N-ECCO
10:10 - 10:30 Recommended for: IBD Nurses, Dietitians
P. Bossuyt, Bonheiden, Belgium
K. Asnong, Bonheiden, Belgium Registration: ECCO Membership 2021 required. Upon
9: Discussion invitation only
A. Inoubli, Saint-Denis, France (ANSM) CME accreditation: N/A
10:30 - 10:50 J. Kirchgesner, Paris, France
P. Bossuyt, Bonheiden, Belgium Friday, July 2, 2021
09:30 - 09:35 1:
K. Asnong, Bonheiden, Belgium Welcome & Introduction
L. Beaugerie, Paris, France M. Ganon, Jerusalem, Israel
10: Closing remarks Session 1: Diagnosis and assessment
10:50 - 10:55 09:35 - 11:55 M. Ganon, Jerusalem, Israel
S. Sebastian, Hull, United Kingdom
M. Campmans-Kuijpers, Groningen, The Netherlands
09:35 - 10:00 2: Diagnosis, anatomy and physiology in IBD
M. Ferrante, Leuven, Belgium
10:00 - 10:20 3: Psychosocial implications of living with IBD
W. Czuber-Dochan, London, United Kingdom
4: Nutritional assessment in IBD
10:20 - 10:40 L. Godny, Petah Tikva, Israel
10:40 - 10:55 Break
10:55 - 11:15 5: Surgery in IBD
M. Adamina, Winterthur, Switzerland
6: Medical treatment
11:15 - 11:35 J. Burisch, Hvidovre, Denmark
11:35 - 11:55 7: Adherence
S. Jäghult, Stockholm, Sweden
11:55 - 12:25 Break
Session 2: Case studies – Disease management
12:25 - 13:15 P. Hartmann, Minden, Germany
A. Ibarra, London, United Kingdom
12:25 - 12:50 8: UC Management
M. Samaan, London, United Kingdom
12:50 - 13:15 9: CD Management
N. Arebi, London, United Kingdom
13:15 - 13:30 Break
Session 3: Multidisciplinary management in IBD
13:30 - 14:15 P. Hartmann, Minden, Germany
W. Czuber-Dochan, London, United Kingdom
13:30 - 13:50 10: Nutritional management in IBD
C. Wall, Christchurch, New Zealand
13:50 - 14:10 11: Nursing roles in IBD management
A. Ibarra, London, United Kingdom
12: Closing remarks
14:10 - 14:15 M. Ganon, Jerusalem, Israel
24 16th Congress of ECCO - European Crohn‘s and Colitis Organisation July 2-3 & 8-10, 2021 • Virtual 258th ECCO Ultrasound Workshop –
Advanced in collaboration with ESGAR
8th ECCO Ultrasound Workshop
– Advanced in collaboration
Free e-Learning with ESGAR
subscription Date:
Time:
Organisation:
Friday, July 2, 2021
13:00-16:35
EduCom in collaboration with ESGAR
Recommended for: Physicians, Radiologists, Surgeons, Paediatricians
Other professions are kindly invited to register.
Registration: ECCO Membership 2021 required
Online registration
Registration fee: 80 EUR (incl. 20% Austrian VAT)
50% reduction for Y-ECCO, Affiliate & IBD Nurse
Members
CME accreditation: 3 CME credits; prerequisite: completion of the
online evaulation form
Friday, July 2, 2021
1: Welcome & Introduction
13:00 - 13:05 C. Maaser, Lüneburg, Germany
J. Rimola, Barcelona, Spain
Session 1: Assessment of IBD
13:05 - 14:35 K. Gecse, Amsterdam, The Netherlands
J. Rimola, Barcelona, Spain
13:05 - 13:15 2: IUS 2021 – What´s new for IUS in CD?
C. Maaser, Lüneburg, Germany
3: Interactive video presentation 1 - IUS in CD - Your
13:15 - 13:35 diagnosis?
Open to all Healthcare Professionals C. Maaser, Lüneburg, Germany
13:35 - 13:45 4: IUS 2021 – What´s new for IUS in UC?
not older than 35 or still in training C. Palmela, Loures, Portugal
5: Interactive video presentation 2 - IUS in UC - Your
13:45 - 14:05 diagnosis?
• Improve your knowledge and enhance your educational C. Palmela, Loures, Portugal
experience with e-CCO Learning
14:05 - 14:15 6: Postoperative monitoring – Tips and Tricks
• Take advantage of advanced learning opportunities in M. Alloca, Rozzano, Italy
IBD with one click 7: Interactive video presentation 3 - Postoperative
• Browse the ECCO e-Library for material as of ECCO’16 14:15 - 14:35 IUS - Your diagnosis
onwards M. Alloca, Rozzano, Italy
• No ECCO Membership required: An ECCO Account is all 14:35 - 14:50 Break
you need
• Log-in via the new ECCO Portal for automatic access
• Renewal of the access every year (if eligible)
Scan and visit
www.e-learning.ecco-ibd.eu July 2-3 & 8-10, 2021 • Virtual 278th ECCO Ultrasound Workshop – 5th Advanced ECCO:
Advanced in collaboration with ESGAR EduCational COurse for Industry
Session 2: IUS special situations
14:50 - 16:35 M. Allocca, Rozzano, Italy 5th Advanced ECCO:
J. Rimola, Barcelona, Spain
14:50 - 15:00 8: Is it IBD? EduCational COurse for
F. Petersen, Lüneburg, Germany
9: Interactive video presentation 4 - What’s your Industry
15:00 - 15:20 diagnosis?
F. Petersen, Lüneburg, Germany Date: Friday, July 2, 2021
10: Contrast enhanced ultrasound and elastography Time: 14:30-17:05
15:20 - 15:30 for IBD monitoring? Organisation: ClinCom
K. Gecse, Amsterdam, The Netherlands Recommended for: Corporate Members & Non-Corporate Members
Registration: ECCO Membership 2021 NOT required
15:30 - 15:50 11: Interactive video presentation 5
F. de Voogd, Amsterdam, The Netherlands Registration fee:
Non-Corporate Members: 600 EUR (incl. 20%
15:50 - 16:00 12: Perineal ultrasound
D. Carter, Ramat Gan, Israel Austrian VAT)
ECCO Corporate Members: 400 EUR (incl. 20%
13: Interactive video presentation 6 Austrian VAT)
16:00 - 16:20 D. Carter, Ramat Gan, Israel
CME accreditation: N/A
16:20 - 16:35 14: Post course test, summary and closing remarks
C. Maaser, Lüneburg, Germany Friday, July 2, 2021
14:30 - 14:35 1: Welcome & Introduction
L. Peyrin-Biroulet, Vandœuvre-Lès-Nancy, France
Session 1: Precision medicine in IBD therapy
14:35 - 15:40 S. Sebastian, Hull, United Kingdom
14:35 - 14:50 2: Precision choice in therapy
S. Vermeire, Leuven, Belgium
14:50 - 15:05 3: Precision risk stratification
E. Louis, Liège, Belgium
15:05 - 15:20 G. Precision
4: monitoring
Rogler, Zurich, Switzerland
5: Discussion
E. Louis, Liège, Belgium
G. Rogler, Zurich, Switzerland
15:20 - 15:40 S. Sebastian, Hull, United Kingdom
S. Vermeire, Leuven, Belgium
K. Park, San Francisco, United States (Roche
Genentech)
15:40 - 15:55 Break
Session 2: How to fill in the gaps of knowledge in
15:55 - 17:05 orphan IBD populations
L. Beaugerie, Paris, France
15:55 - 16:10 6: Clinical trials: Lessons from the past
G. D‘Haens, Amsterdam, The Netherlands
7: Orphan fields in IBD
16:10 - 16:25 K. Gecse, Amsterdam, The Netherlands
16:25 - 16:40 8: Filling the Gaps
S. Danese, Rozzano, Italy
28 16th Congress of ECCO - European Crohn‘s and Colitis Organisation July 2-3 & 8-10, 2021 • Virtual 295th Advanced ECCO: 7th Y-ECCO Basic Science Workshop
EduCational COurse for Industry
9: Discussion
L. Beaugerie, Paris, France 7th Y-ECCO Basic Science
G. D‘Haens, Amsterdam, The Netherlands
16:40 - 17:00 K. Gecse, Amsterdam, The Netherlands
S. Danese, Rozzano, Italy
Workshop
S. Milicevic, Zurich, Switzerland (Takeda) Date: Friday, July 2, 2021
A. Rose, London, United Kingdom (Patient Time: 14:30-17:45
Representative) Organisation: Y-ECCO
17:00 - 17:05 10: Closing remarks Recommended for: Basic scientists, Physicians, Paediatricians,
S. Sebastian, Hull, United Kingdom Surgeons, IBD Nurses
Other professions are kindly invited to register.
Registration: ECCO Membership 2021 required
Online registration
Registration fee: 65 EUR (incl. 20% Austrian VAT)
50% reduction for Y-ECCO, Affiliate & IBD Nurse
Members
CME accreditation: 2 CME credits; prerequisite: completion of the
online evaulation form
Friday, July 2, 2021
14:30 - 14:35 1: Introduction
C. Hedin, Stockholm, Sweden
Session 1: Systems biology
14:35 - 15:40 C. Hedin, Stockholm, Sweden
S. Schreiber, Kiel, Germany
14:35 - 14:55 2: Generating complex data to unravel IBD
S. Schreiber, Kiel, Germany
3: Abstract presentation: αEβ7 positive γδ T cells are
14:55 - 15:10 associated with mucosal healing in Ulcerative Colitis
and have a homeostatic immunophenotype
R. Dart, London, United Kingdom
4: Abstract presentation: Ulcerative Colitis
associated single nucleotide polymorphisms
15:10 - 15:25 found in transcription factor binding sites effect
key pathogenesis pathways and facilitate patient
stratification
D. Modos, Cambridge, United Kingdom
5: Abstract presentation: Serum proteomics predict
15:25 - 15:40 endoscopic remission in patients with Crohn’s
Disease
D. Alsoud, Leuven, Belgium
15:40 - 15:50 Break
30 16th Congress of ECCO - European Crohn‘s and Colitis Organisation July 2-3 & 8-10, 2021 • Virtual 317th Y-ECCO Basic Science Workshop 6th D-ECCO Workshop
Session 2: Modelling IBD
15:50 - 16:55 M. Samaan, London, United Kingdom 6th D-ECCO Workshop
S. Zeissig, Dresden, Germany
Date: Saturday, July 3, 2021
15:50 - 16:10 6: Models of IBD
S. Zeissig, Dresden, Germany Time: 08:15-11:50
Organisation: D-ECCO
7: Abstract presentation: Endoscopically injected
allogeneic mesenchymal stromal cells alter the Recommended for: Dietitians, IBD Nurses, Physicians
16:10 - 16:25 mucosal immune cell compartment in patients with Other professions are kindly invited to register.
Ulcerative Proctitis Registration: ECCO Membership 2021 required
L. Ouboter, Amsterdam, The Netherlands Online registration
8: Abstract presentation: Effects of exposure to Registration fee: 40 EUR (incl. 20% Austrian VAT)
CME accreditation: 3 CME credits; prerequisite: completion of the
16:25 - 16:40 steroids on the PredictSURE whole blood prognostic
assay in Inflammatory Bowel Disease online evaulation form
D. Alsoud, Leuven, Belgium
9: Abstract presentation: Development of human Saturday, July 3, 2021
embryonic stem cell-derived intestinal organoids
16:40 - 16:55 for in vitro studies on intestinal inflammation and 08:15 - 08:20 1: Welcome
M. Campmans-Kuijpers, Groningen, The Netherlands
fibrosis Session 1: Science, diet and IBD
E. Filidou, Alexandroupolis, Greece 08:20 - 09:30 C. Wall, Christchurch, New Zealand
16:55 - 17:05 Break D. O‘Hanlon, London, United Kingdom
Session 3: Basic Science Reserach Fellowships 08:20 - 08:38 2: Food additives and their effect on the microbiome
A. Levine, Holon, Israel
17:05 - 17:40 J. Burisch, Hvidovre, Denmark
G. Pellino, Aversa, Italy
08:38 - 08:56 3: Personalized nutrition in IBD – Are we there yet?
L. Godny, Petah Tikva, Israel
17:05 - 17:25 10: From bench to research group leader
R. Atreya, Erlangen, Germany
08:56 - 09:15 4: Fermented foods – fad or fix?
M. Campmans-Kuijpers, Groningen, The Netherlands
11: ECCO Fellowship presentation: Targeting CD4+
17:25 - 17:40 T-cell plasticity in IBD 5: The future of using nutrition to alter the
A. Machicote, Hamburg, Germany 09:15 - 09:30 microbiome
12: Closing remarks and Y-ECCO best abstract E. Wine, Edmonton, Canada
17:40 - 17:45 awards 09:30 - 09:45 Break
J. Burisch, Hvidovre, Denmark Session 2: Practical clinical nutrition in IBD
09:45 - 10:30 M. Campmans-Kuijpers, Groningen, The Netherlands
L. Godny, Petah Tikva, Israel
09:45 - 10:00 6: Nutritional assessment
E. Halmos, Melbourne, Australia
10:00 - 10:15 7: Eating for Two: Nutrition and Pregnancy
C. Wall, Christchurch, New Zealand
8: OMG it’s OFG: Dietary management of Orofacial
10:15 - 10:30 granulomatous
D. O‘Hanlon, London, United Kingdom
10:30 - 10:45 Break
32 16th Congress of ECCO - European Crohn‘s and Colitis Organisation July 2-3 & 8-10, 2021 • Virtual 336th D-ECCO Workshop 1st ECCO Postgraduate Course in IBD
Session 3: Panel discussion / Interactive session
10:45 - 11:50 C. Wall, Christchurch, New Zealand
1st ECCO Postgraduate Course
D. O‘Hanlon, London, United Kingdom
9: Abstract presentation 1: Food-related quality of
in IBD
life in adults with Inflammatory Bowel Disease is
Date: Saturday, July 3, 2021
10:45 - 10:55 influenced by restrictive eating behaviour, disease
activity and surgery: A prospective multi-centre Time: 08:30-12:25
study Organisation: EduCom
A. Day, Adelaide, Australia Recommended for: Experienced Gastroenterologists with interest in
10: Abstract presentation 2: Risk of eating IBD
disorders in Italian children and adolescents with Other professions are kindly invited to register.
10:55 - 11:05 Inflammatory Bowel Disease: results of a multicenter Registration: ECCO Membership 2021 required
nationwide study Online registration
S. Gatti, Ancona, Italy Registration fee: 65 EUR (incl. 20% Austrian VAT)
11: Will emerging diets replace medical therapy in CME accreditation: 3 CME credits; prerequisite: completion of the
online evaulation form
11:05- 11:25 IBD?
E. Halmos, Melbourne, Australia
M. Samaan, London, United Kingdom
12: Interactive Session
Saturday, July 3, 2021
E. Halmos, Melbourne, Australia 1: Introduction
08:30 - 08:35 P.
11:25- 11:45 M. Samaan, London, United Kingdom Juillerat, Bern, Switzerland
C. Wall, Christchurch, New Zealand H. Yanai, Petah Tikva, Israel
D. O‘Hanlon, London, United Kingdom F. Magro Dias, Porto, Portugal
Session 1: Prepare yourself with IBD Experts
11:45 - 11:50 13: Closing remarks
M. Campmans-Kuijpers, Groningen, The Netherlands 08:35 - 10:05 P. Juillerat, Bern, Switzerland
J. van der Woude, Rotterdam, The Netherlands
08:35 - 08:50 2: How important is IBD?
S. Vermeire, Leuven, Belgium
3: How to diagnose and evaluate a new IBD case?
08:50 - 09:05 L. Peyrin-Biroulet, Vandœuvre-Lès-Nancy, France
09:05 - 09:30 4: How to optimise the old school IBD Meds?
S. Ben-Horin, Ramat Gan, Israel
09:30 - 09:55 5: How to place new biologics and small molecules?
S. Danese, Rozzano, Italy
09:55 - 10:05 6: How to place surgery in IBD?
P. Kotze, Curitiba, Brazil
10:05 - 10:20 Break
Session 2: Case-based discussion with IBD Experts
10:20 - 12:25 H. Yanai, Petah Tikva, Israel
P. Juillerat, Bern, Switzerland
10:20 - 10:50 7: UC cases presentation
S. Restellini, Geneva, Switzerland
8: Discussion
S. Restellini, Geneva, Switzerland
10:50 - 11:20 P. Juillerat, Bern, Switzerland
G. Doherty, Dublin, Ireland
G. Rogler, Zurich, Switzerland
34 16th Congress of ECCO - European Crohn‘s and Colitis Organisation July 2-3 & 8-10, 2021 • Virtual 3510th S-ECCO IBD Masterclass in
1st ECCO Postgraduate Course in IBD collaboration with ESCP
11:20 - 11:50 9: CD cases presentation
T. Lobatón, Leuven, Belgium
10: Discussion
10th S-ECCO IBD Masterclass
T. Lobatón, Leuven, Belgium
11:50 - 12:20 H. Yanai, Petah Tikva, Israel
in collaboration with ESCP
B. Siegmund, Berlin, Germany Date: Saturday, July 3, 2021
J. Colombel, New York, United States
Time: 08:30-16:00
11: Conclusion and remarks Organisation: S-ECCO in collaboration with ESCP
12:20 - 12:25 P. Juillerat, Bern, Switzerland Recommended for: Surgeons, Physicians, IBD Nurses
H. Yanai, Petah Tikva, Israel Other professions are kindly invited
F. Magro Dias, Porto, Portugal
to register.
Registration: ECCO Membership 2021 required
Online registration
Registration fee: 120 EUR (incl. 20% Austrian VAT)
50% reduction for Y-ECCO, Affiliate & IBD Nurse
Members
CME accreditation: 4 CME credits; prerequisite: completion of the
online evaulation form
Saturday, July 3, 2021
08:30 - 08:35 1: Welcome
M. Adamina, Winterthur, Switzerland
Session 1: Hot questions in IBD surgery: The
08:35 - 09:55 fistulizing session
O. Faiz, Harrow, United Kingdom
Y. Panis, Clichy, France
08:35 - 09:15 Debate 1: What to do with these abdominal fistula?
08:35 - 08:50 2: Enterocutaneous fistula
P. Myrelid, Linköping, Sweden
08:50 - 09:05 G. Urinary
3: fistula
Sampietro, Milan, Italy
4: Discussion
09:05 - 09:15 P. Myrelid, Linköping, Sweden
G. Sampietro, Milan, Italy
09:15 - 09:55 Debate 2: Pelvic fistula is a nightmare!
09:15 - 09:30 5: Pouch fistula
W. Bemelman, Amsterdam, The Netherlands
09:30 - 09:45 6: Rectovaginal fistula
P. Fleshner, Los Angeles, United States
7: Discussion
09:45 - 09:55 W. Bemelman, Amsterdam, The Netherlands
P. Fleshner, Los Angeles, United States
09:55 - 10:05 Break
36 16th Congress of ECCO - European Crohn‘s and Colitis Organisation July 2-3 & 8-10, 2021 • Virtual 3710th S-ECCO IBD Masterclass in 10th S-ECCO IBD Masterclass in
collaboration with ESCP collaboration with ESCP
Session 2: The scientific IBD surgeon: 13:20 - 13:30 Break
10:05 - 11:05 Trial updates 13:30 - 14:30 S-ECCO IBD Masterclass Satellite Symposium Slot
C. Buskens, Amsterdam, The Netherlands 14:30 - 14:40 Break
P. Myrelid, Linköping, Sweden
Session 4: Expertise in IBD management: What does
10:05 - 10:20 9: Perioperative pathway of care in IBD patients
14:40 - 15:25 it mean?
M. Adamina, Winterthur, Switzerland M. Adamina, Winterthur, Switzerland
10:20 - 10:35 10: Achieving high performance in IBD surgery P. Kotze, Curitiba, Brazil
O. Faiz, Harrow, United Kingdom
14:40 - 14:55 25: How to train to become IBD surgeon?
10:35- 11:05 Trial updates G. Pellino, Aversa, Italy
13: The VALIDate study: Giving a voice to the IBD 26: Transitioning paediatric patients to adults IBD
10:35 - 10:45 patient 14:55 - 15:10 care
C. Le Berre, Nantes, France D. Wilson, Edinburgh, United Kingdom
14: The MIND study: Assessment of psychological 27: Perineal sinus after total coloproctectomy for
10:45 - 10:55 characteristics and postop outcomes 15:10 - 15:25 CD: How to prevent? How to treat?
C. Foppa, Milan, Italy P. Kienle, Mannheim, Germany
15: The COSTA study : COlonic Salvage by Session 5: Consultants’ corner on challenging cases
10:55 - 11:05 Therapeutic Appendectomy M. Adamina, Winterthur, Switzerland
C. Buskens, Amsterdam, The Netherlands
15:25 - 15:55 P. Kotze, Curitiba, Brazil
11:05 - 11:15 Break P. Fleshner, Los Angeles, United States
W. Bemelman, Amsterdam, The Netherlands
Session 3: Ten years after: The history of IBD surgery A. Hart, London, United Kingdom
11:15 - 13:20 W. Bemelman, Amsterdam, The Netherlands
15:25 - 15:40 28:
P. Kienle, Mannheim, Germany First clinical case
M. Carvello, Rozzano, Italy
11:15 - 11:30 16: 10 years of surgery for intestinal Crohn’s Disease
15:40 - 15:55 29:
A. D‘Hoore, Leuven, Belgium Second clinical case
P. Tozer, London, United Kingdom
11:30 - 11:45 18: 10 years of surgery for Crohn’s perineal disease
30: Closing remarks
P. Kotze, Curitiba, Brazil 15:55 - 16:00 M. Adamina, Winterthur, Switzerland
17: 10 years of surgery for Ulcerative Colitis
11:45 - 12:00 Y. Panis, Clichy, France
12:00 - 12:10 19: Ten years after: The S-ECCO history
C. Buskens, Amsterdam, The Netherlands
12:10 - 12:40 Surgical technique session: How I do it ?
20: Adapting surgical strategy to preoperative
12:10 - 12:25 treatment
A. Lightner, Cleveland, United States
12:25 - 12:40 21: TTSS for low anastomosis in IBD patients
A. Spinelli, Rozzano, Italy
12:40 - 13:20 Surgical technique session: The redo-session
12:40 - 12:55 22: Redo pouch
J. Warusavitarne, Harrow, United Kingdom
12:55 - 13:10 23: Redosurgery for intestinal Crohn’s Disease
O. Zmora, Tel Aviv, Israel
24: Discussion
13:10 - 13:20 J. Warusavitarne, Harrow, United Kingdom
O. Zmora, Tel Aviv, Israel
38 16th Congress of ECCO - European Crohn‘s and Colitis Organisation July 2-3 & 8-10, 2021 • Virtual 396th H-ECCO IBD Masterclass 6th H-ECCO IBD Masterclass
11: Modification of IBD histology by medical and
6th H-ECCO IBD Masterclass 11:30 - 11:45 surgical therapy
M. Tripathi, Cambridge, United Kingdom
Date: Saturday, July 3, 2021 11:45 - 12:00 12: Datasets and standards for IBD pathology
R. Feakins, London, United Kingdom
Time: 09:00-15:55
13: Slide seminar
12:00 - 12:10 P. Baldin,
Organisation: H-ECCO, endorsed by ESP Woluwe Saint Lambert, Belgium
Recommended for: Histopathologists, Clinicians
Other professions are kindly invited to register. 12:10- 12:40 Break
Registration: ECCO Membership 2021 required Session 3: Neoplasia
Online registration 12:40 - 14:10 J. Lindsay, London, United Kingdom
M. Svrcek, Paris, France
Registration fee: 65 EUR (incl. 20% Austrian VAT)
50% reduction for Y-ECCO, Affiliate & IBD Nurse 12:40 - 12:55 14: Tumours in IBD – Clinician
J. Lindsay, London, United Kingdom
Members
CME accreditation: 5 CME credits; prerequisite: completion of the 15: Primary sclerosing cholangitis and
online evaulation form 12:55 - 13:10 cholangiocarcinoma
F. Rosini, Bologna, Italy
Saturday, July 3, 2021 13:10 - 13:25 16: Nonepithelial neoplasia in IBD
P. Baldin, Woluwe Saint Lambert, Belgium
09:00 - 09:05 1: Welcome & Introduction
G. De Hertogh, Leuven, Belgium
13:25 - 13:40 17: Neuroendocrine proliferations in IBD
S. Walsh, Dundee, United Kingdom
Session 1: Basics of IBD
09:05 - 10:30 P. Bossuyt, Bonheiden, Belgium
A. Driessen, Edegem, Belgium 13:40 - 13:50 18: Slide seminar
A. Driessen, Edegem, Belgium
09:05- 09:20 2: Patient’s view: What are the priorities?
P. Hartmann, Minden, Germany
19: Intestinal adenocarcinoma in IBD
13:50 - 14:10 M. Svrcek, Paris, France
09:20 - 09:35 3: Surgeon’s view: When is pathology useful?
M. Adamina, Winterthur, Switzerland
14:10 - 14:25 Break
Session 4: New concepts
09:35 - 09:50 M.Pathologist’s
4: view: Macroscopic pathology of IBD
Tripathi, Cambridge, United Kingdom
14:25 - 15:50 G. De Hertogh, Leuven, Belgium
P. Baldin, Woluwe Saint Lambert, Belgium
09:50 - 10:05 5: Pathologist’s view: Biopsy features of IBD
P. Baldin, Woluwe Saint Lambert, Belgium 14:25 - 14:40 20: Hot topics in IBD
G. De Hertogh, Leuven, Belgium
10:05 - 10:20 6: Gastroenterologist’s view: Features of IBD
P. Irving, London, United Kingdom 21: Fibrosis in IBD and its assessment
14:40 - 14:55 R. Feakins, London, United Kingdom
7: Slide seminar – Macroscopic pathology of IBD
10:20 - 10:30 F. Rosini, 22: Digital pathology and artificial intelligence in
Bologna, Italy 14:55 - 15:10 IBD pathology
10:30 - 10:45 Break F. Rosini, Bologna, Italy
Session 2: Scoring schemes and standards 15:10 - 15:25 23: Newer and rarer mimics of IBD histology
A. Driessen, Edegem, Belgium
10:45- 12:10 F. Rosini, Bologna, Italy
R. Feakins, London, United Kingdom
15:25 - 15:40 24: The pancreas and IBD
I. Esposito, Düsseldorf, Germany
8: Sampling issues – Clinician and pathologist
10:45 - 11:00 F. Magro Dias, Porto, Portugal 25: Slide seminar
A. Driessen, Edegem, Belgium 15:40 - 15:50 G. De Hertogh, Leuven, Belgium
9: Scoring schemes for IBD – Clinician and
15:50 - 15:55 26: Closing remarks
11:00 - 11:15 pathologist
F. Magro Dias, Porto, Portugal
G. De Hertogh, Leuven, Belgium
G. De Hertogh, Leuven, Belgium
10: Discussion about scoring systems
11:15 - 11:30 F. Magro Dias, Porto, Portugal
A. Driessen, Edegem, Belgium
G. De Hertogh, Leuven, Belgium
40 16th Congress of ECCO - European Crohn‘s and Colitis Organisation July 2-3 & 8-10, 2021 • Virtual 419th SciCom Workshop 15th N-ECCO Network Meeting
9th SciCom Workshop: 15th N-ECCO Network Meeting
Precision medicine in IBD: Disease Date: Saturday, July 3, 2021
prevention, progression and therapy Time: 10:00-15:00
Organisation: N-ECCO
outcomes Target audience: IBD Nurses - advanced level
Date: Saturday, July 3, 2021 Registration: ECCO Membership 2021 required
Online registration
Time: 09:45-11:45
Registration fee: 20 EUR (incl. 20% Austrian VAT)
Organisation: SciCom
CME accreditation: N/A
Recommended for: Basic scientists and interested clinicians
Other professions are kindly invited to register.
Registration: ECCO Membership 2021 required
Online registration Saturday, July 3, 2021
Registration fee: 65 EUR (incl. 20% Austrian VAT) 10:00 - 10:05 1: Welcome & Introduction
S. Jäghult, Stockholm, Sweden
50% reduction for Y-ECCO, Affiliate & IBD Nurse
Members Session 1: Treatments in IBD
CME accreditation: 1 CME credit; prerequisite: completion of the 10:05 - 11:05 P. Hartmann, Minden, Germany
online evaulation form S. Jäghult, Stockholm, Sweden
Saturday, July 3, 2021 10:05 - 10:20 2: What is new in IBD treatment?
B. Siegmund, Berlin, Germany
Precision medicine in IBD - Part 1 3: Complimentary treatment
10:20 - 10:35 J. Langhorst,
09:45 - 10:35 M. Ferrante, Leuven, Belgium Bamberg, Germany
S. Zeissig, Dresden, Germany
10:35 - 10:50 4: CBD and marihuana
09:45 - 09:50 1: Welcome & Introduction
S. Zeissig, Dresden, Germany
U. Kopylov, Tel Aviv, Israel
10:50 - 11:05 5: Faecal transplantation as treatment in IBD
09:50 - 10:12 2: Can you prevent disease
J. Torres, Loures, Portugal
A. Hart, London, United Kingdom
11:05 - 11:20 Break
3: Prediction of the disease course
10:12 - 10:35 J. Lee, Cambridge, United Kingdom Session 2: Innovation in Research and practice
11:20 - 12:20 W. Czuber-Dochan, London, United Kingdom
10:35 - 10:50 Break E. Kjaer-Mikkelsen, Herning, Denmark
Precision medicine in IBD - Part 2
10:50 - 11:45 M. Scharl, Zurich, Switzerland 11:20 - 11:40 6: Polypharmacy in older patients
A. Hart, London, United Kingdom
K. Papamichail, Boston, United States
7: Abstract Presentation 1: N01: Does physical
10:50 - 11:12 4: Predicting response to therapy
B. Verstockt, Leuven, Belgium 11:40 - 11:50 activity positively impact fatigue in individuals with
Inflammatory Bowel Disease?
5: Can you cure established disease D. Farrell, Cork, Ireland
11:12 - 11:40 Y. Panis, Clichy, France 8: Abstract Presentation 2: N02: PREVIEW study:
C. Fiocchi, Cleveland, United States Factors associated with willingness to switch from
11:40 - 11:45 6: Closing remarks
M. Scharl, Zurich, Switzerland 11:50 - 12:00 intravenous to subcutaneous formulations of CT-
P13 and vedolizumab in patients with Inflammatory
Bowel Disease.
K. Asnong, Bonheiden, Belgium
9: Abstract Presentation 3: N03: Information flow
12:00 - 12:10 experiences during COVID-19 in IBD patients: A
prospective observational study
E. De Dycker, Rotselaar, Belgium
42 16th Congress of ECCO - European Crohn‘s and Colitis Organisation July 2-3 & 8-10, 2021 • Virtual 4315th N-ECCO Network Meeting 8th P-ECCO Educational Course
10: Abstract Presentation 4: N04: Being an IBD
Clinical Nurse Specialist in the UK National
12:10 - 12:20 Health Service: Challenges, Stressors and Coping
8th P-ECCO Educational Course
Mechanisms Date: Saturday, July 3, 2021
L. Dibley, London, United Kingdom Time: 13:05-14:25
12:20 - 12:25 Break Organisation: P-ECCO
12:25 - 13:25 N-ECCO Network Meeting Satellite Symposium Slot Recommended for: Paediatricians, Physicians, Surgeons
13:25 - 13:35 Break Other professions are kindly invited to register.
Registration: ECCO Membership 2021 required
Session 3: IBD Nurse role in management of IBD Online registration
13:35 - 14:10 A. Ibarra, London, United Kingdom
A. Rivera, Barcelona, Spain Registration fee: 65 EUR (incl. 20% Austrian VAT)
50% reduction for Y-ECCO, Affiliate & IBD Nurse
11: Ongoing Symptoms in patients in remission – Members
13:35 - 13:50 How to deal with them?
G. Rogler, Zurich, Switzerland CME accreditation: 1 CME credit; prerequisite: completion of the
online evaulation form
12: Nurses role in surgical pathway - A Tandem talk
13:50 - 14:10 K. Kemp, Manchester, United Kingdom
J. Odita, London, United Kingdom
14:10 - 14:25 Break
Saturday, July 3, 2021
13:05 - 14:25 Food for thought in IBD
14:25 - 14:55 Session 4: MDT Session – Q&A Session
W. Czuber-Dochan, London, United Kingdom D. Wilson, Edinburgh, United Kingdom
13: Q&A Session
13:05 - 13:10 1: Welcome
S. Jäghult, Stockholm, Sweden D. Wilson, Edinburgh, United Kingdom
E. Langholz, Herlev, Denmark 2: Contemporary nutritional approach in adult IBD
14:25 - 14:55 P. Myrelid, Linköping, Sweden 13:10 - 13:30 I. Dotan, Petah Tikva, Israel
M. Campmans-Kuijpers, Groningen, The Netherlands L. Godny, Petah Tikva, Israel
A. Duff, London, United Kingdom
L. Inganäs, Stockholm, Sweden 3: Multidisciplinary approaches for nutritional thera-
13:30 - 13:50 py at the poles of the life cycle - PIBD and elderly IBD
14:55- 15:00 14: Closing remarks
S. Jäghult, Stockholm, Sweden D. O’Hanlon, London, United Kingdom
E. Wine, Edmonton, Canada
13:50 - 14:05 4: Nutritional issues at transition in IBD
M. Aloi, Rome, Italy
14:05 - 14:25 5: Towards personalized dietary therapy
J. Van Limbergen, Amsterdam, The Netherlands
44 16th Congress of ECCO - European Crohn‘s and Colitis Organisation July 2-3 & 8-10, 2021 • Virtual 45You can also read
